Issue Date: April 25, 2011
Rhodia Analgesics Are Sold To Novacap
Rhodia is selling its business in the bulk analgesics aspirin and acetaminophen to Novacap, a French firm that was created in 2003 out of several former Rhodia businesses. The deal, which also includes the intermediates salicylic acid and methyl salicylate, involves plants in France, China, Thailand, and Brazil that collectively employ about 390 people. Rhodia is in the process of being acquired by Solvay in a $4.8 billion deal.
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society